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Abstract 
Purpose: To investigate the effect of recombinant adenovirus-mediated human β-nerve growth factor 
(Ad-EGFP-hβ-NGF) on the differentiation of endothelial progenitor cells (EPCs) in rats.  
Methods: The successfully constructed Ad-EGFP-hβ-NGF and its negative control Ad-EGFP were 
infected into the isolated and purified rat EPCs to observe their morphological changes. Enzyme-linked 
immunosorbent assay (ELISA) was conducted to detect the levels of vascular endothelial growth factor 
(VEGF), von Willebrand factor (vWF) and basic fibroblast growth factor (bFGF) in different rat EPC 
culture solutions. Western blot was performed to determine the expression of tyrosine kinase receptor A 
(TrKA) protein in different groups of EPCs.  
Results: Primary fibrous EPCs were converted into epithelium-like cells. After infection with Ad-EGFP-
hβ-NGF for 1 week, some EPCs became round and exhibited neural stem cell-like changes. The 
expression levels of VEGF, vWF and bFGF in the Ad-EGFP-hβ-NGF infection group were significantly 
higher than those in the control group (p < 0.01). TrKA protein in Ad-EGFP-hβ-NGF infection was also 
significantly up-regulated compared with that in the negative control and blank control groups (p < 0.01).  
Conclusion: β-NGF up-regulates the expression of TrKA receptor protein and secretion of angiogenic 
growth factors (i.e., VEGF, vWF and bFGF), thereby promoting the differentiation of rat EPCs, which 
may contribute to angiopoiesis or vascular repair. 
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Endothelial progenitor cells (EPCs), also known 
as angioblasts, are bone marrow-derived stem 
cells characterised by migration; thus, these cells 
can further proliferate and differentiate into 
vascular endothelial cells[1]. EPCs play 
important roles in vivo to promote vascular 
regeneration, repair damaged endothelial 
functions and improve local blood perfusion [2]. 
Thus, EPCs are clinically significant. According 
to our previous clinical studies, autologous 
peripheral blood stem cell transplantation can 
effectively improve the outcomes of diabetic 
peripheral vascular disease [3,4]. 
 
Nerve growth factor (NGF) is a nerve cell growth 
regulator that is firstly found amongst 
neurotrophic factors. NGF contains three 
subunits (i.e., α, β and γ), and the active region is 
the β subunit. β-NGF is a dimer consisting of two 
single-strands through noncovalent bonds [5]. 
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Recent studies have shown that in addition to its 
neurotrophic roles, NGF participates in promoting 
angiogenesis in damaged tissues [6]. In this 
study, recombinant adenovirus-mediated β-NGF 
was infected into rat EPCs to investigate its 
effects on EPC differentiation by determining 
whether NGF promotes endothelial regeneration 




Reagents and instruments 
 
Four-week-old male SD rats weighing 60-80 g 
were provided by the Experimental Animal 
Center of Tongji Medical College. The following 
reagents were used in this study: Percoll cell 
separation solution (Pharmacia, USA), EGM-
2MV culture medium (Lonza, Switzerland), rabbit 
anti-human CD34 antibody and isotype control 
murine IgG1 antibody (Abcam Inc), rabbit anti-
human VEGF ELISA assay kit (R&D, USA), 
rabbit anti-human vWF ELISA assay kit (China), 
rabbit anti-human bFGF ELISA assay kit (China), 
rabbit anti-rat tyrosine kinase receptor A (TrKA; 
Santa, USA), rabbit anti-rat actin (Santa, USA), 
secondary antibodies (Beijing Zhongshan) and 
ECL (Beyotime Biotechnology Co. Ltd). Other 
reagents were of analytical grade. FACSCalibur 
flow cytometer (BD Co.), 5810R high-speed low-
temperature centrifuge (Eppendorf Co.) and 
microplate reader (Bio-Rad, Inc) were also 
employed. 
 
Isolation and purification of rat EPCs 
 
The rats were anaesthetised, decapitated and 
then soaked in 75 % ethanol for 15 min. 
Afterward, the femur and tibia were sampled and 
soaked into 0.9 % precooled NaCl solution (4 
°C). The marrow cavity was then repeatedly 
flushed with saline until the rinsing solution was 
clear. The cells were pipetted evenly and slowly 
added into centrifuge tubes containing Percoll 
cell separation solution. This study was approved 
by Animal Ethics Committee of Huazhong 
University of Science and Technology (ref no. 
2016005022). All the experimental procedures 
were performed in accordance with the 
International Guidelines for Care and Use of 
Laboratory Animals [7]. 
 
The volume ratio of the rinsing solution to the 
separation solution was 2:1. After centrifugation 
at 2500 rpm for 20 min, the milky cloudy 
mononuclear cells (MNCs) in the middle of the 
centrifuge tube were gently sucked and moved 
into a new tube and then rinsed with PBS twice 
(1300 r/min, 8 min). Subsequently, 20% FBS-
containing EBM-2MV culture medium was used 
to resuspend the cells and then gently pipetted 
repeatedly to make a single cell suspension.  
 
The cell suspension was seeded into 6 cm dish 
with a density of 1 × 106 cells/mL and incubated 
at 37 °C in 5% CO2 and saturated humidity. After 
4 days, the medium was totally changed for the 
first time. The suspended cells were discarded, 
and the rest of the cells were stored for culture. 
The medium was changed every 3 days. 
Meanwhile, the morphological changes of the 
cells were observed. On the 14th day (the cells 
grew to 80 % confluence), 0.25 % trypsin was 
used to digest the dish wall-adherent cells. The 
cells were also passaged (1:2), and the culture 




Adenovirus-mediated human β-nerve growth 
factor (Ad-EGFP-hβ-NGF) and its negative 
control Ad-EGFP were provided by Dr Jianing 
Wang of the Clinical College of Hubei Medical 
College. The EPCs of rats cultured until the 28th 
day were divided into three groups and infected 
with Ad-EGFP-hβ-NGF and Ad-EGFP with 100 
multiplicity of infection. Meanwhile, the blank 
control group was prepared. After 48 h infection, 
the cell morphological changes were 
continuously observed. 
 
Expression and detection of TrKA protein 
through Western blot 
 
After 48 h infection, the cells were washed with 
precooled PBS, and the supernatant was 
discarded. Precooled (4 °C) tissue protein extract 
solution (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 
1 % NP-40, 100 μg/ml PMSF, 0.5 % 
deoxycholate, 0.02 % sodium azide, and 1 μg/ml 
aprotinin) was added, and the mixture was then 
incubated on ice for 15 min. The cells were then 
lysed on ice via ultrasound. The supernatant 
(obtained by 10 min centrifugation at 4 °C and 
12000 rpm) was used to determine the protein 
concentration with BCA assay, and the protein 
detected using 12 % SDS-PAGE electrophoresis, 
membrane transfer, and incubation with primary 
antibodies (TrKA 1:2000, Actin 1:10000) and 
secondary antibody (1:10000). ECL 
chemiluminescence method was used for the 
coloration, and Syngene gel imaging system was 
employed to photograph, record and analyse the 
results. 
 
Detection of VEGF, vWF and bFGF in the 
culture supernatant by ELISA 
 
After the cells were infected for 6 days, the 
culture supernatant was collected and 
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centrifuged at room temperature (2000 rpm, 3 
min). VEGF, vWF and bFGF were detected using 
ELISA kits according to the manufacturer’s 
instructions. The optical density of each well was 
determined using a microplate reader at 450 nm. 





SPSS 13.0 software was used for the statistical 
analysis. Data are expressed as mean ± 
standard deviation (SD), and multi-group 
comparisonwas performed using one-way 
ANOVA and pair-wise comparison (LSD 





Morphological characteristics of EPCs 
 
MNCs began to adhere to wall and became large 
when seeded for 24 h. Inverted microscope 
observation revealed that the transparency of the 
wall-adherent cells was enhanced. Moreover, the 
border became clear, and the cells became small 
rod-shaped or spindle. After cultivation for 7 
days, the wall-adherent cells began the ‘colony-
like’ proliferation with numerous spindle 
peripheral cells. In the second week, the spindle 
cells increased significantly. When cultured until 
the 28th day, the spindle cells adhered to one 
another and exhibited ‘paving stone-like’ 
arrangement.  
 
EPCs that formed at different periods are shown 
in Figure 1. The EPCs cultured for 28 days were 
infected with adenovirus (the negative control 
and blank control groups were set at the same 
time). After 48 h, the cell morphological 
observation under a fluorescence-inverted 
phase-contrast microscope revealed the 
expression of green fluorescent protein in the Ad-
EGFP-hβ-NGF and Ad-EGFP groups. However, 
the control group had no fluorescence. The 
infection effects in different groups are shown in 
Figure 2. One week after the infection, some 
cells exhibited neurosphere-like proliferation. 
However, the negative control and blank control 
groups showed no corresponding proliferation, 
as shown in Figure 3. 
 
Expression and detection of TrKA protein 
through Western blot  
 
After the cells were infected for 48 h, the total 
cellular proteins were extracted for immunoblot 
assay. The results revealed that TrKA was 
significantly upregulated in the Ad-EGFP-hβ-
NGF group than that in the Ad-EGFP and blank 
control groups (P< 0.01), as shown in Figure 4. 
 
Detection of VEGF, vWF and bFGF levels in 
the culture supernatants through enzyme-
linked immunosorbent assay (ELISA) 
 
After the EPCs were infected for 6 days, the cell 
culture media were collected for the detection of 
VEGF, vWF and bFGF through ELISA. All these  
 




        Figure 2: Expressions of green fluorescent protein in different groups  
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        Figure 3: Cells exhibited neurosphere-like proliferation after infection with Ad-EGFP-hβ-NGF for 1 week
 
Figure 4: TrKA expression levels in different treatment 
groups 
 
three factors in the Ad - EGFP - hβ-NGF group 
were significantly upregulated compared with 
those in the Ad-EGFP and blank control groups 




EPCs are responsible for maintaining the 
dynamic equilibrium of endothelial injury and 
repair, and their quantity and functions are 
directly related to the occurrence and 
development of vascular diseases [8]. Under 
certain induction conditions, EPCs can promote 
angiogenesis in ischemic areas and increase 
collateral circulation. The proangiogenesis 
mechanisms of EPCs have been confirmed, 
which mainly include two aspects,(1) Self-
proliferation and differentiation to form new blood 
vessels without reliance on the original organ 
system, (2) EPCs can secrete cytokines, such as 
VEGF or bFGF, thereby promoting the 
proliferation of local vascular endothelial cells via 
paracrine; in particular, the angiogenetic effects 
are enhanced, thereby improving blood supply 
[9]. During EPC differentiation, the regulation of 
proangiogenic factors and their receptors plays 
active roles, and they participate in different 
stages, amongst which the proangiogenetic 
effects of VEGF, bFGF and vWF have been 
demonstrated [10]. 
 
NGF is a nerve cell growth regulator that is firstly 
discovered amongst neurotrophic factors, and 
has important regulatory roles towards the 
development, differentiation, growth, 
regeneration and expression of functional 
properties of the central and peripheral neurons 
[11-13]. Recent studies have demonstrated that 
NGF directly promotes angiogenesis mainly 
through vascular endothelial cell-associated 
effects [14]. In this study, Ad - EGFP - hβ-NGF 
and Ad-EGFP were successfully infected into rat 
EPCs, and we observed that all the cells adhered 
to wall grew in the control group. The cells also 
changed from fibroblast-like cells to epithelial 
cells with time. However, the differentiation rate 
of the cells in the Ad - EGFP - hβ-NGF group 
decreased, but the proliferation rate increased. 
Some cells also exhibited neurosphere-like 
proliferation. These observations indicate that 
NGF could maintain and restore the features of 
EPCs, which are conducive in maintaining the 
EPC bank and providing adequate cell source for 
vascular repair and generation. After the EPCs 
were infected with NGF, cell proliferation was 
evident, showing similar roles of VEGF, bFGF or 
vWF; this phenomenon established the 
foundation for angiogenesis. 
 
Several studies demonstrated that EPCs have 
two receptors, namely, TrKA and P75 
neurotrophin receptor that mediate the signal 
transduction of NGF. The former possesses high 
affinity, whereas the latter has low affinity. The 
TrKA receptor generally mediates positive 
signals and mainly promotes cell survival and 
proliferation. When NGF binds the TrKA 
receptor, it can regulate the affinity of its receptor 
and the TrKA signal transduction. First, NGF 
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         Table 1: ELISA data for different groups (mean± SEM, ng/ml) 
 
Group VEGF vWF bFGF 
Blank 0.185±0.057 0.361±0.058 0.394±0.029 
Ad-EGFP-hβ-NGF 0.535±0.097* 0.594±0.025* 0.682±0.068* 
Ad-EGFP 0.204±0.076 0.403±0.039 0.349±0.057 
         *P<0.01 
 
stimulates the expression and secretion of matrix 
metalloproteinase-2, thereby regulating 
phosphatidyl inositol 3-kinase (PI3K)/AKT 
signalling pathway by increasing the 
phosphorylation of TrKA and the activity of PI3K. 
Therefore, the main mechanism of NGF in 
angiogenesis is to exert its biological effects by 
binding its high-affinity receptor TrKA. At present, 
the capillaries and aortic endothelial cells in 
mice, as well as human umbilical vein endothelial 
cells, can produce NGF and express the TrKA 
protein. ELISA and immunohistochemical 
techniques are used to assess ischemic 
muscles; the endogenous NGF and its high-
affinity receptor TrKA are upregulated, and the 
administration of exogenous NGF can 
significantly improve the limb ischemic conditions 
[15]. 
 
The results of this study showed that when rat 
EPCs were infected with Ad - EGFP - hβ-NGF, 
the cells exhibited neurosphere-like proliferation, 
and the expression levels of VEGF, vWF, bFGF 
and TrKA protein in cell culture medium were 
significantly upregulated. Therefore, NGF may 
regulate the stem cell properties of EPCs, and 
the expression levels and secretions of 
proangiogenic factors (i.e., VEGF, vWF and 
bFGF) and TrKA protein may be upregulated, 
thereby promoting angiogenesis. However, the 
proangiogenetic abilities of NGF should still be 




β-NGF upregulates the expression of TrKA 
receptor protein and the secretion of angiogenic 
growth factors (i.e., VEGF, vWF and bFGF), 
thereby promoting the differentiation of rat EPCs. 
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